Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia

SIMPLE SUMMARY: Infusions of T-cells genetically modified to recognize the protein CD19 (CD19 CAR-T cells) have proven a potent form of cancer therapy for certain cancers arising from B-cells. These treatments, while revolutionary, remain expensive to manufacture using a patients’ own cells and can...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurney, Mark, O’Dwyer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036691/
https://www.ncbi.nlm.nih.gov/pubmed/33805422
http://dx.doi.org/10.3390/cancers13071568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036691/
https://www.ncbi.nlm.nih.gov/pubmed/33805422
http://dx.doi.org/10.3390/cancers13071568

Ejemplares similares